Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo MRI assessment of position dependent capsulolabral gap differences between neutral and flexion abduction external rotation hip positions.

Scientific reports·2026
Same author

Comparison between a T-tube and a spiralflow-tube to improve the visualization ability of the subclavian artery in CT angiography from the neck to the aortic arch.

Radiological physics and technology·2026
Same author

Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II.

Cureus·2026
Same author

Relationship between pelvic incidence and hip, pelvic, and lumbar motion during squatting in healthy individuals with high and low pelvic incidence.

Scientific reports·2026
Same author

[Implementation Report: Attempt for a Decision of Priorities in Measures to Prevent Recurrence of Low-level Incidents Using Priority Monitoring Score].

Nihon Hoshasen Gijutsu Gakkai zasshi·2025
Same author

A highly sensitive enzyme‑linked immunosorbent assay allows accurate measurements of brain‑derived neurotrophic factor levels in human saliva.

F1000Research·2025

Related Experiment Video

Updated: Jun 17, 2026

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
08:22

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

[Fully automated immunoassay system utilizing microchip electrophoresis].

Takuma Ohtsubo1, Isao Yamaguchi, Tatsuo Kurosawa

  • 1Wako Pure Chemical Industries Ltd., Osaka 540-8605, Japan.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 25, 2009
PubMed
Summary

This study presents a novel micro Total Analysis System (microTAS) for rapid and sensitive PIVKA II immunoassay. The system offers high accuracy and efficiency for hepatocellular carcinoma diagnosis.

More Related Videos

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Related Experiment Videos

Last Updated: Jun 17, 2026

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
08:22

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Clinical Diagnostics

Context:

  • Microfluidic devices offer advantages for clinical diagnostics, including reduced reaction times and sample volumes.
  • Traditional immunoassays can be time-consuming and require larger sample volumes.
  • Microchip electrophoresis combined with isotachophoresis provides efficient separation and immunoreaction capabilities.

Purpose:

  • To develop a fully automated microfluidic immunoassay system for PIVKA II detection.
  • To evaluate the performance of the microTAS system in terms of sensitivity, reproducibility, and correlation with existing methods.
  • To demonstrate the utility of the developed system for clinical applications, specifically in hepatocellular carcinoma diagnosis.

Summary:

  • A novel microTAS system was developed using isotachophoresis and capillary gel electrophoresis on polymer microchips for a fully automated immunoassay.
  • Laser-Induced Fluorescence (LIF) detected sandwich immunocomplexes, demonstrating high sensitivity (LOD = 5mAU/mL) and reproducibility (CV = 1.0-5.7%) for PIVKA II.
  • The assay showed excellent correlation with a commercial kit (r=0.991) and a rapid turnaround time of approximately 9 minutes.

Impact:

  • The developed microTAS system provides a rapid, sensitive, and reproducible method for PIVKA II detection.
  • This technology has the potential to significantly improve the diagnosis and prognosis of hepatocellular carcinoma.
  • The system's efficiency and reduced reagent consumption highlight the advantages of microfluidic devices in clinical diagnostics.